 2. Measurable soft tissue or lymph node metastases or any metastatic disease outside the bone that is RECIST measurable will be an exclusion unless it is pelvic nodal disease 1.5cm in short axis. Bone metastases with associated soft tissue components will also not be an exclusion. 